3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
4
Prostatic Neoplasms, Castration-Resistant
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Neoplasms
1
Adrenocortical Carcinoma
1
Interventions
Blood Specimen Collection
4
Liquid Biopsy
2
cabazitaxel
1
Sevoflurane
1
Radiotherapy
1
Propofol
1
Positron Emission Tomography Computed Tomography
1
Oxaliplatin
1
Neoadjuvant Therapy
1
Needles
1
Microfluidics
1
Lymph Node Excision
1
Leucovorin
1
Laparoscopy
1
Ipilimumab
1
Histamine H2 Antagonists
1
Histamine Antagonists
1
Ethiodized Oil
1
Epirubicin
1
Drug Therapy
1
Diagnostic Imaging
1
Circulating Tumor DNA
1
Chemoembolization, Therapeutic
1
Cell-Free Nucleic Acids
1
Capecitabine
1
CA-72-4 antigen
1
CA-19-9 Antigen
1
Biopsy, Fine-Needle
1
Aspirin
1
Antiemetics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplastic Cells, Circulating
×
cabazitaxel
×
Clear all
NCT03050866
2021-08-20
CABA-V7
Erasmus Medical Center
Phase 2
Unknown
140 enrolled